Medications for Parathyroid Neoplasms
7 results
Cinacalcet (cinacalcet)
(Cinacalcet)American Health Packaging
Usage: Cinacalcet is indicated for treating secondary hyperparathyroidism in adults with chronic kidney disease on dialysis, hypercalcemia in parathyroid carcinoma, and severe hypercalcemia in primary hyperparathyroidism patients who cannot undergo surgery. It is not indicated for non-dialysis patients due to hypocalcemia risk.
Cinacalcet (cinacalcet)
(Cinacalcet)Bryant Ranch Prepack
Usage: Cinacalcet is indicated for the treatment of secondary hyperparathyroidism in adults with chronic kidney disease on dialysis, hypercalcemia in parathyroid carcinoma, and severe hypercalcemia in primary hyperparathyroidism patients who cannot undergo surgery. It is not recommended for those with chronic kidney disease not on dialysis due to hypocalcemia risk.
Cinacalcet (cinacalcet)
(Cinacalcet)Camber Pharmaceuticals, Inc.
Usage: Cinacalcet tablets are indicated for treating secondary hyperparathyroidism in adults with chronic kidney disease on dialysis, hypercalcemia in parathyroid carcinoma, and severe hypercalcemia in primary hyperparathyroidism when surgery is not an option. Not indicated for non-dialysis CKD patients due to hypocalcemia risk.
Cinacalcet (cinacalcet)
(Cinacalcet)Aurobindo Pharma Limited
Usage: Cinacalcet tablets are indicated for treating secondary hyperparathyroidism in adults with chronic kidney disease on dialysis, hypercalcemia in parathyroid carcinoma patients, and hypercalcemia in primary hyperparathyroidism when parathyroidectomy is not an option. Not for use in CKD patients not on dialysis due to hypocalcemia risk.
Cinacalcet (cinacalcet)
(Cinacalcet)Major Pharmaceuticals
Usage: Cinacalcet tablets are indicated for treating secondary hyperparathyroidism in adults with chronic kidney disease on dialysis, hypercalcemia in parathyroid carcinoma patients, and severe hypercalcemia in primary hyperparathyroidism when surgery is not an option. It is not for patients with CKD not on dialysis due to hypocalcemia risk.
Cinacalcet hydrochloride (cinacalcet hydrochloride)
(cinacalcet hydrochloride)Slate Run Pharmaceuticals
Usage: Cinacalcet tablets are indicated for treating secondary hyperparathyroidism in adults with chronic kidney disease on dialysis, and for hypercalcemia in adults with parathyroid carcinoma or primary hyperparathyroidism who cannot undergo parathyroidectomy. It is not recommended for CKD patients not on dialysis due to hypocalcemia risk.
Sensipar (cinacalcet hydrochloride)
(cinacalcet hydrochloride)Amgen Inc
Usage: Sensipar is indicated for the treatment of secondary hyperparathyroidism in adults with chronic kidney disease on dialysis, hypercalcemia in parathyroid carcinoma patients, and hypercalcemia in primary hyperparathyroidism patients unable to undergo parathyroidectomy. It is not indicated for patients with CKD not on dialysis due to hypocalcemia risk.